Next, we determined the effect of KLK6 inhibition on tumour cell proliferation and migration and treated a panel of PDAC cell lines with the same APPI-4M concentration (100 nM), which reduced the migratory behaviour of breast cancer cells in our earlier study [18]. This evidence concerns the gene KLK6 and breast carcinoma.